CinCor Pharma
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $193M
Investors
- 14
About CinCor Pharma
Based in Ohio, US, and founded in 2018, CinCor Pharma, Inc. operates as a clinical-stage cardiorenal therapeutics company. Catherine Pearce is a co-founder of the company. Marc de Garidel is the CEO of the company as of 2021. In January 2023, AstraZeneca acquired CinCor Pharma, Inc.3 billion. The transaction was completed in February 2023. The company researches and develops biopharmaceuticals for the treatment of cardio-renal diseases. CIN-107, a highly selective oral small molecule inhibitor of aldosterone synthase, is the company's lead asset and is being tested in clinical trials for the treatment of resistant hypertension and primary aldosteronism. CinCor Pharma, Inc.
Who invested in CinCor Pharma
14 investors across 2 rounds
See all investors in CinCor Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CinCor Pharma
Who invested in CinCor Pharma?
CinCor Pharma has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CinCor Pharma raised?
CinCor Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CinCor Pharma last raise money?
CinCor Pharma's most recent round on record is a Series B, in Sep 2021.
What does CinCor Pharma do?
Based in Ohio, US, and founded in 2018, CinCor Pharma, Inc.
Where is CinCor Pharma headquartered?
CinCor Pharma is headquartered in Waltham, US.
Which VCs invest in companies like CinCor Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CinCor Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like CinCor Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.